Blog

Japanese universities to acquire stock option rights as IP license fees

Posted on
licensing revenues of universities

Previously on this blog, we featured a story about a fight on patent royalty between a university researcher and a licensee company. And, it suggested a problem of a talent shortage for intellectual property in the university.  Licensing Revenues of Japanese Universities When talking about licensing revenues of universities, Japanese universities are often compared with American universities. […]

Blog

Japanese Nobel laureate seeking to gain the support of the public to raise royalty rate for Opdivo patents

Posted on
Fighting over patent royalty rate

Japanese scientist Tasuku Honjo, a winner of the Nobel Prize in physiology or medicine in 2018, is fighting over patent royalty rate against Ono Pharmaceutical, a Japanese pharmaceutical company. Background Reportedly, in 2006, Honjo and Ono entered a license agreement for the patents on PD-1 which was applied to the cancer drug Opdivo (nivolumab). However, […]